<div id="subtitle">Bristol-Myers 4th-qtr profit rises on higher sales of key drugs, gain from Mead Johnson sale</div><div><p>Stronger sales of nearly all its medicines and a multibillion-dollar, one-time gain brought drugmaker Bristol-Myers Squibb Co. a huge jump in fourth-quarter profit, the company said Thursday.</p&gt ...

<div id="subtitle">Drugmaker Bristol-Myers Squibb sees jump in 2010 profit to range of $1.94 to $2.04 per share</div><div><p>Drugmaker Bristol-Myers Squibb Co. said Thursday that it expects earnings per share this year to range from $1.94 to $2.04.</p><p&gt ...

<div id="subtitle">Bristol-Myers Squibb, after nutrition business sale, has new pure pharma focus, $8B for deals</div><div><p>Bristol-Myers Squibb Co., the world's No. 15 drugmaker by revenue, reports fourth-quarter earnings Thursday. The following is a summary of key developments and analyst opinion related to the period.</p ...